On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction.

RATIONALE AND OBJECTIVES In patients with severe emphysema and poor quality of life, bronchoscopic lung volume reduction (BLVR) may be considered and guided based on lobar emphysema severity. In particular, x-ray computed tomography (CT) emphysema measurements are used to identify the most diseased and the second-most diseased lobes as BLVR targets. Inhaled gas magnetic resonance imaging (MRI) also provides chronic obstructive pulmonary disease (COPD) biomarkers of lobar emphysema and ventilation abnormalities. Our objective was to retrospectively evaluate CT and MRI biomarkers of lobar emphysema and ventilation in patients with COPD eligible for BLVR. We hypothesized that MRI would provide complementary biomarkers of emphysema and ventilation that help determine the most appropriate lung lobar targets for BLVR in patients with COPD. MATERIALS AND METHODS We retrospectively evaluated 22 BLVR-eligible patients from the Thoracic Imaging Network of Canada cohort (diffusing capacity of the lung for carbon monoxide = 37 ± 12%predicted, forced expiratory volume in 1 second = 34 ± 7%predicted, total lung capacity = 131 ± 17%predicted, and residual volume = 216 ± 36%predicted). Lobar CT emphysema, measured using a relative area of <-950 Hounsfield units (RA950) and MRI ventilation defect percent, was independently used to rank lung lobe disease severity. RESULTS In 7 of 22 patients, there were different CT and MRI predictions of the most diseased lobe. In some patients, there were large ventilation defects in lobes not targeted by CT, indicative of a poorly ventilated lung. CT and MRI classification of the most diseased and the second-most diseased lobes showed a fair-to-moderate intermethod reliability (Cohen κ = 0.40-0.59). CONCLUSIONS In this proof-of-concept retrospective analysis, quantitative MRI ventilation and CT emphysema measurements provided different BLVR targets in over 30% of the patients. The presence of large MRI ventilation defects in lobes next to CT-targeted lobes might also change the decision to proceed or to guide BLVR to a different lobar target.

[1]  L. Edwards,et al.  Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. , 2013, Respiratory medicine.

[2]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[3]  J R Brookeman,et al.  Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. , 1999, Radiology.

[4]  Endoscopic lung volume reduction in severe emphysema. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  Aaron Fenster,et al.  Hyperpolarized 3He Ventilation Defects and Apparent Diffusion Coefficients in Chronic Obstructive Pulmonary Disease: Preliminary Results at 3.0 Tesla , 2007, Investigative radiology.

[6]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[7]  C. Marquette,et al.  Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. , 2016, JAMA.

[8]  G. Parraga,et al.  Hyperpolarized ³He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. , 2011, European journal of radiology.

[9]  F. Herth,et al.  Endoscopic Lung Volume Reduction , 2009, Respiration.

[10]  G. Snell,et al.  Lung volume reduction surgery for emphysema , 1997, The Medical journal of Australia.

[11]  John P Mugler,et al.  Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes--initial experience. , 2002, Radiology.

[12]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[13]  Miranda Kirby,et al.  Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps. , 2016, Radiology.

[14]  F. Herth,et al.  Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. , 2016, The Lancet. Respiratory medicine.

[15]  M. Decramer,et al.  No room to breathe: the importance of lung hyperinflation in COPD , 2013, Primary care respiratory journal : journal of the General Practice Airways Group.

[16]  Miranda Kirby,et al.  Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. , 2012, Academic radiology.

[17]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[18]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[19]  S. Bicknell,et al.  Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. , 2013, The Lancet. Respiratory medicine.

[20]  Bram van Ginneken,et al.  Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema. , 2007, Radiology.

[21]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[22]  F. Herth,et al.  Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema , 2012, International journal of chronic obstructive pulmonary disease.

[23]  Miranda Kirby,et al.  Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. , 2012, Radiology.

[24]  Suresh Senan,et al.  Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. , 2012, International journal of radiation oncology, biology, physics.

[25]  Jan Wolber,et al.  Diffusion‐weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease , 2011, Magnetic resonance in medicine.

[26]  G. McLennan,et al.  A randomized study of endobronchial valves for advanced emphysema. , 2010, The New England journal of medicine.

[27]  M. McHugh.  Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[28]  Carla G. Wilson,et al.  Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. , 2013, AJR. American journal of roentgenology.

[29]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[30]  Miranda Kirby,et al.  Longitudinal Computed Tomography and Magnetic Resonance Imaging of COPD: Thoracic Imaging Network of Canada (TINCan) Study Objectives. , 2014, Chronic obstructive pulmonary diseases.

[31]  Kevin M. Johnson,et al.  Optimized 3D ultrashort echo time pulmonary MRI , 2013, Magnetic resonance in medicine.

[32]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[33]  John P Griffin,et al.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.

[34]  D. Hansell,et al.  Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial , 2015, The Lancet.

[35]  F. Martinez,et al.  Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. , 2006, The Annals of thoracic surgery.

[36]  F. Herth,et al.  Current status of bronchoscopic lung volume reduction with endobronchial valves , 2013, Thorax.

[37]  Miranda Kirby,et al.  Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. , 2010, Radiology.

[38]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[39]  A Potthast,et al.  Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. , 1996, Radiology.

[40]  Susan Murray,et al.  Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease , 2012, Thorax.

[41]  F. Martinez,et al.  The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. , 2011, American journal of respiratory and critical care medicine.

[42]  L. R. Dice.  Measures of the Amount of Ecologic Association Between Species , 1945 .

[43]  Michael Brady,et al.  MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration , 2012, Medical Image Anal..

[44]  F. Herth,et al.  The Localized Inflammatory Response to Bronchoscopic Thermal Vapor Ablation , 2013, Respiration.

[45]  E. V. van Rikxoort,et al.  Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. , 2015, The New England journal of medicine.

[46]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[47]  A. Iwasaki,et al.  Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD). , 2005, The Thoracic and cardiovascular surgeon.

[48]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[49]  Arieh Eden,et al.  Patients at High Risk of Death After Lung-Volume-Reduction Surgery , 2002 .

[50]  B. Yaremko,et al.  Magnetic resonance imaging biomarkers of chronic obstructive pulmonary disease prior to radiation therapy for non-small cell lung cancer , 2015, European journal of radiology open.

[51]  Miranda Kirby,et al.  Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. , 2014, Radiology.

[52]  F. Herth,et al.  Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema , 2011, European Respiratory Journal.

[53]  E. V. van Rikxoort,et al.  Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial , 2014, Thorax.